Low-dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma

Cancer Commun (Lond). 2022 Oct;42(10):909-912. doi: 10.1002/cac2.12347. Epub 2022 Aug 4.

Authors

Yu-Pei Chen¹, Jia-Yi Shen¹, Zhen-Ji Deng¹, Ying Sun¹, Xiao-Yu Liang¹, Jia-Wei Lv¹, Jun Ma¹

Affiliation

¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine of Sun Yat-sen University, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Metronomic
Humans
Nasopharyngeal Carcinoma / drug therapy
Nasopharyngeal Neoplasms* / drug therapy
Xenograft Model Antitumor Assays